Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b KW-6356 add-on therapy in Parkinson's disease on levodopa
jRCT2080224050Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sipagladenant in Parkinson's disease (PD) (3 arms), sponsored by Kyowa Kirin. Started Sep 2018; status: completed.
02
Drugs
sipagladenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080224050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224050.